Literature DB >> 9241710

Familial thrombophilia: a complex genetic disorder.

B P Koeleman1, P H Reitsma, R M Bertina.   

Abstract

Familial thrombosis has long been considered as an autosomal dominant trait, caused by a dominant gene defect with a reduced penetrance for the disease. Recently, this view has changed and today familial thrombophilia is considered as a complex genetic disorder caused by the segregation of two or more gene defects (known and unknown) in a family. Here we briefly discuss the known genetic defects (protein C, protein S, and antithrombin deficiency and activated protein C resistance associated with factor V Leiden) with special focus on the relation between gene mutation and plasma abnormality and on the association between abnormality and thrombosis in affected families and in the population. Finally, the evidence is reviewed that indicates familial thrombosis as an oligogenetic disorder and on the basis of these data strategies are discussed for the identification of new genetic risk factors for thrombosis via a genetic approach.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241710

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  11 in total

Review 1.  Thrombophilia: a genetic predisposition to thrombosis.

Authors:  R A Sacher
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

2.  A novel protein S gene mutation combined with protein S Tokushima mutation in a patient with superior sagittal sinus thrombosis.

Authors:  Akihiro Shindo; Makoto Ikejiri; Yuichiro Ii; Kaname Nakatani; Hideo Wada; Tsutomu Nobori; Hidekazu Tomimoto
Journal:  J Neurol       Date:  2011-06-07       Impact factor: 4.849

Review 3.  Duration of anticoagulation after cerebral venous sinus thrombosis.

Authors:  Frances Caprio; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

4.  Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.

Authors:  E Mandala; C Lafaras; C Tsioni; M Speletas; A Papageorgiou; D Kleta; T Dardavessis; G Ilonidis
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

5.  Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: how long should we treat these patients with warfarin?

Authors:  Ivana Jukic; Marina Titlic; Ante Tonkic; Daniel Rosenzweig
Journal:  J Thromb Thrombolysis       Date:  2007-01-24       Impact factor: 5.221

6.  A genome-wide association study of the Protein C anticoagulant pathway.

Authors:  Georgios Athanasiadis; Alfonso Buil; Juan Carlos Souto; Montserrat Borrell; Sonia López; Angel Martinez-Perez; Mark Lathrop; Jordi Fontcuberta; Laura Almasy; José Manuel Soria
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

7.  Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-11-28       Impact factor: 2.576

8.  Hereditary thrombophilia.

Authors:  Salwa Khan; Joseph D Dickerman
Journal:  Thromb J       Date:  2006-09-12

9.  Cavernous sinus and generalized venous thrombosis following rhinoplasty in a young patient.

Authors:  Mohammad Motamed Shariati; Ahmad Meymane Jahromi
Journal:  World J Plast Surg       Date:  2012-07

10.  Acute Anorectal Thrombophlebitis Caused by a Protein C Deficiency.

Authors:  Yuji Eso; Satoshi Yoshiji; Yuto Nakakubo; Minoru Matsuura; Hiroshi Seno
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.